Health chiefs must act now to allow millions of people to benefit from “statins for the brain”, scientists say.

Justin Bone detailed the days leading up to his arrest, describing taking drugs and wandering various parts of the city after ...

Alector said on Wednesday that GSK had terminated their neuroscience collaboration agreement covering two experimental ...

With an increasingly aging global population and no available preventive treatments, Alzheimer's disease and related ...

Accumulation of DNA damage in the brain's neurons may contribute to the development of Alzheimer's disease. New research in ...

Vaccinex, Inc., a clinical-stage biotechnology company pioneering a differentiated approach to treating Alzheimer’s disease (AD) through the inhibition of Semaphorin 4D (SEMA4D), today announced that ...

For more than a century, Alzheimer’s disease has been considered a condition that cannot be reversed. Doctors have focused on slowing the disease because they believed the damage to brain cells could ...

A drug that raises levels of histamine – the chemical that causes allergy symptoms – in the brain boosts our memory by around ...

In today’s Daily, a peek at Estonia, where decades of hard-won progress against fentanyl gave way to something far deadlier. New dementia research out of Curtin University finds that nearly half of ...

Ambitious studies have been examining the protective effects of diet, exercise and socializing — with surprising results.

Parkinson's disease (PD) is the second most common form of neurodegenerative disease and afflicts more than ten million ...

Providers reported Alzheimer’s treatment gains with Zunveyl in long-term care, but the BEACON study cannot prove cause and ...